Shigehiro Doi

2.7k total citations · 1 hit paper
71 papers, 2.1k citations indexed

About

Shigehiro Doi is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Shigehiro Doi has authored 71 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Nephrology, 18 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Shigehiro Doi's work include Dialysis and Renal Disease Management (21 papers), Parathyroid Disorders and Treatments (17 papers) and Chronic Kidney Disease and Diabetes (11 papers). Shigehiro Doi is often cited by papers focused on Dialysis and Renal Disease Management (21 papers), Parathyroid Disorders and Treatments (17 papers) and Chronic Kidney Disease and Diabetes (11 papers). Shigehiro Doi collaborates with scholars based in Japan, United States and Sweden. Shigehiro Doi's co-authors include Takao Masaki, Noriaki Yorioka, Ayumu Nakashima, Toshiki Doi, Nobuoki Kohno, Osamu Togao, Toshinori Ueno, Kensuke Sasaki, Makoto Kuro‐o and Masaya Takahashi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Shigehiro Doi

68 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Klotho Inhibits Transforming Growth Factor-β1 (TGF-β1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice

2011 466 citations Shigehiro Doi, Yonglong Zou et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shigehiro Doi Japan	22	889	707	359	337	285	71	2.1k
Tetsuya Kawamura Japan	25	974 1.1×	1.1k 1.5×	434 1.2×	142 0.4×	309 1.1×	131	2.6k
Siân Griffin United Kingdom	20	772 0.9×	448 0.6×	204 0.6×	223 0.7×	306 1.1×	48	1.6k
Prudence A. Hill Australia	22	867 1.0×	747 1.1×	253 0.7×	180 0.5×	320 1.1×	41	2.2k
Marie Jeansson Sweden	19	911 1.0×	807 1.1×	301 0.8×	196 0.6×	203 0.7×	28	2.0k
M. Golam Kabir Canada	22	704 0.8×	971 1.4×	426 1.2×	128 0.4×	462 1.6×	28	2.7k
Uta Kunter Germany	29	1.2k 1.3×	1.1k 1.6×	640 1.8×	173 0.5×	342 1.2×	49	3.0k
Sandra Merscher United States	26	1.6k 1.8×	1.2k 1.7×	342 1.0×	314 0.9×	302 1.1×	56	2.9k
Darren A. Yuen Canada	25	515 0.6×	765 1.1×	316 0.9×	99 0.3×	274 1.0×	74	2.1k
Sandeep K. Mallipattu United States	29	731 0.8×	862 1.2×	171 0.5×	279 0.8×	160 0.6×	66	2.0k
Jean‐Claude Dussaule France	33	609 0.7×	862 1.2×	329 0.9×	119 0.4×	483 1.7×	89	2.9k

Countries citing papers authored by Shigehiro Doi

Since Specialization

Citations

This map shows the geographic impact of Shigehiro Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigehiro Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigehiro Doi more than expected).

Fields of papers citing papers by Shigehiro Doi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigehiro Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigehiro Doi. The network helps show where Shigehiro Doi may publish in the future.

Co-authorship network of co-authors of Shigehiro Doi

This figure shows the co-authorship network connecting the top 25 collaborators of Shigehiro Doi. A scholar is included among the top collaborators of Shigehiro Doi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigehiro Doi. Shigehiro Doi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sasaki, Kensuke, Ayumu Nakashima, Akira Takahashi, et al.. (2023). Comparison of survival rates between incident hemodialysis patients and peritoneal dialysis patients: a 5-year prospective cohort study with propensity score matching. Clinical and Experimental Nephrology. 27(5). 419–426. 3 indexed citations

Doi, Shigehiro, et al.. (2022). Upregulation of Mineralocorticoid Receptor Contributes to Development of Salt-Sensitive Hypertension after Ischemia–Reperfusion Injury in Rats. International Journal of Molecular Sciences. 23(14). 7831–7831. 3 indexed citations

Ishiuchi, Naoki, Ayumu Nakashima, Shigehiro Doi, et al.. (2021). Serum-free medium and hypoxic preconditioning synergistically enhance the therapeutic effects of mesenchymal stem cells on experimental renal fibrosis. Stem Cell Research & Therapy. 12(1). 472–472. 20 indexed citations

Nakashima, Ayumu, Ryo Tamura, Naoki Ishiuchi, et al.. (2021). Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis. Stem Cell Research & Therapy. 12(1). 203–203. 21 indexed citations

Nakashima, Ayumu, Shigehiro Doi, Ken Yoshida, et al.. (2021). Interferon-γ enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis. Scientific Reports. 11(1). 850–850. 44 indexed citations

Doi, Shigehiro, et al.. (2020). Comparison of 5-Year Survival Rate Between Hemodialysis and Peritoneal Dialysis Patients: A Prospective Cohort Study with Propensity Score Matching. Journal of the American Society of Nephrology. 31(10S). 357–357.

Hayashi, Ryohei, Yoshitaka Ueno, Shinji Tanaka, et al.. (2020). Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy. Intestinal Research. 19(4). 430–437. 8 indexed citations

Ishiuchi, Naoki, Ayumu Nakashima, Shigehiro Doi, et al.. (2020). Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats. Stem Cell Research & Therapy. 11(1). 130–130. 85 indexed citations

Ueno, Toshinori, Shigehiro Doi, Ayumu Nakashima, et al.. (2019). High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate ≥60 mL/min/1.73 m2: A cross-sectional study. PLoS ONE. 14(8). e0218290–e0218290. 13 indexed citations

10.

Mizuiri, Sonoo, Yoshiko Nishizawa, Takayuki Naito, et al.. (2019). Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients. Renal Failure. 41(1). 770–777. 18 indexed citations

11.

Doi, Shigehiro, et al.. (2019). Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16. Kidney International. 96(5). 1162–1175. 40 indexed citations

12.

Nakashima, Ayumu, Takeshi Kawamoto, Mitsuhide Noshiro, et al.. (2018). Dec1 and CLOCK Regulate Na ⁺ /K ⁺ -ATPase β1 Subunit Expression and Blood Pressure. Hypertension. 72(3). 746–754. 33 indexed citations

13.

Doi, Shigehiro, Ayumu Nakashima, Kyoko Yamada, et al.. (2016). Valproic acid attenuates renal fibrosis through the induction of autophagy. Clinical and Experimental Nephrology. 21(5). 771–780. 36 indexed citations

14.

Nakashima, Ayumu, Shigehiro Doi, Toshinori Ueno, et al.. (2015). High glucose promotes TGF-β1 production by inducing FOS expression in human peritoneal mesothelial cells. Clinical and Experimental Nephrology. 20(1). 30–38. 9 indexed citations

15.

Ueno, Toshinori, Shigehiro Doi, Ayumu Nakashima, et al.. (2015). The Serum Lipids Levels may be Underestimated in Patients on Hemodialysis. Internal Medicine. 54(8). 887–894. 4 indexed citations

16.

Shiraki, Nobuaki, Ayumu Nakashima, Shigehiro Doi, et al.. (2013). Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis. Clinical and Experimental Nephrology. 18(3). 499–506. 10 indexed citations

17.

Doi, Shigehiro, Yonglong Zou, Osamu Togao, et al.. (2011). Klotho Inhibits Transforming Growth Factor-β1 (TGF-β1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice. Journal of Biological Chemistry. 286(10). 8655–8665. 466 indexed citations breakdown →

18.

Arakawa, Toshiya, Takao Masaki, Toshiro Hirai, et al.. (2008). Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis. Nephrology Dialysis Transplantation. 23(11). 3418–3426. 48 indexed citations

19.

Kawai, Tōru, Takao Masaki, Shigehiro Doi, et al.. (2008). PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β. Laboratory Investigation. 89(1). 47–58. 185 indexed citations

20.

Nakashima, Ayumu, Noriaki Yorioka, Shigehiro Doi, et al.. (2003). Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels. Bone. 34(3). 579–583. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact